Planta Med 1999; 65(5): 413-416
DOI: 10.1055/s-1999-14017
Original Paper

Georg Thieme Verlag Stuttgart · New York

Evaluation of the Anti-Plasmodial Activity of Bisbenzylisoquinoline Alkaloids from Abuta grandifolia

Jonathan C. P.  Steele1, 2 , Monique S. J. Simmonds1, 2 , Nigel C. Veitch1 , David C. Warhurst2
  • 1 Jodrell Laboratory, Royal Botanic Gardens, Kew, Richmond, Surrey, U.K.
  • 2 Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, U.K.
Weitere Informationen

Publikationsverlauf

October 23, 1998

February 7, 1999

Publikationsdatum:
31. Dezember 1999 (online)

Abstract

Three alkaloids were isolated from the bark of the traditional medicinal plant Abuta grandifolia (Mart.) Sandw. (Menispermaceae) and tested for in vitro anti-plasmodial activity. Two of them were identified as the Type VIII bisbenzylisoquinoline alkaloids, krukovine (1) and limacine (2), while the least abundant compound (3) could only be characterised to Type I of the same class. Krukovine exhibited potent anti-plasmodial activity with IC50 values of 0.44 μg/ml and 0.022 μg/ml against K1 (chloroquine-resistant) and T9-96 (chloroquine-sensitive) Plasmodium falciparum, respectively. Both limacine and compound 3 exhibited moderate anti-plasmodial activity against K1 with IC 50 values of 1.35 μg/ml and 1.58 μg/ml, respectively. Limacine gave an IC50 value of 0.24 μg/ml against T9-96. Krukovine and limacine showed greater activity against T9-96 than against K1, exhibiting similar activity profiles to that of chloroquine diphosphate (0.187 μg/ml and 0.013 μg/ml against K1 and T9-96, respectively). This indicates that krukovine and limacine may be affected by the mechanism of chloroquine resistance present in K1 P. falciparum .

    >